Cargando…
Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
Cystic fibrosis (CF) is an autosomal recessive disease associated with recurrent lung infections that can lead to morbidity and mortality. The impact of antibiotics for treatment of acute pulmonary exacerbations on the CF airway microbiome remains unclear with prior studies giving conflicting result...
Autores principales: | Hahn, Andrea, Bendall, Matthew L., Gibson, Keylie M., Chaney, Hollis, Sami, Iman, Perez, Geovanny F., Koumbourlis, Anastassios C., McCaffrey, Timothy A., Freishtat, Robert J., Crandall, Keith A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980964/ https://www.ncbi.nlm.nih.gov/pubmed/29887843 http://dx.doi.org/10.3389/fmicb.2018.01069 |
Ejemplares similares
-
Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
por: Hahn, Andrea, et al.
Publicado: (2018) -
2573. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Lung Microbiome Diversity and Pulmonary Function
por: Jason. Bozzella, Michael, et al.
Publicado: (2019) -
Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
por: Shumyatsky, Gabriella, et al.
Publicado: (2023) -
Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2021) -
Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
por: Hahn, Andrea, et al.
Publicado: (2020)